UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: ABASAGLAR-100eml-Solution-SE-IS-MPD-BBDL

ABASAGLAR 100 enheter/ml Injektionsvätska, lösning i cylinderampull

MPID: SE-100000426-00049703
EURDID: 1751

Full name: ABASAGLAR 100 enheter/ml Injektionsvätska, lösning i cylinderampull

- Invented name part: ABASAGLAR

- Strength part: 100 enheter/ml

- Pharmaceutical dose form part: Injektionsvätska, lösning i cylinderampull

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Solution for injection in cartridge

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 A10AE04
  • 100000155059 Centralised procedure
  • 200000027129 CHMP Rapporteur
  • 200000027126 PRAC Co-Rapporteur

Marketing Authorisation 1 of 1

Authorisation number: 49703

Region: Kingdom of Sweden

Marketing authorisation holder: Eli Lilly Nederland B.V.

Identifier:

  • LOC-100005434

Status: Valid (2014-09-09)

Package 1 of 1

PCID:

Description:
Cylinderampull, 5 st (5 x 3 ml)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 5 Cartridge

Package: 1 Box (Cardboard)

Containing:

Package: 5 Cartridge (Glass type I) (Rubber) (Aluminium)

Containing: 3 millilitre(s)

Manufactured Item

Dose form: Solution for injection in cartridge

Unit of presentation: Cartridge

Ingredient

Role: Active

Substance: Insulin glargine

Concentration strength: 100 unit(s) / 1 millilitre(s)

Reference strength:
Insulin glargine 100 unit(s) / 1 millilitre(s)

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Subcutaneous use

Ingredients:

Ingredient

Role: Active

Substance: Insulin glargine

Concentration strength: 100 unit(s) / 1 millilitre(s)

Reference strength:
Insulin glargine 100 unit(s) / 1 millilitre(s)